October 11, 2023
Moving beyond static evidence development to ensure local market access success; responding to recent changes in...
Read article
August 28, 2023
A clinical development plan — a comprehensive strategy for developing an investigational product through regulatory...
Read article
February 1, 2021
Cytel’s COVID-19 Trial Tracker continues to provide real time updates to the status of COVID-19 clinical trials...
Read article
January 11, 2021
In April 2020, Cytel launched an open-access global COVID-19 Clinical Trial Tracker to help facilitate greater...
Read article
December 15, 2020
When designing clinical trials, biostatisticians and clinical development teams are often faced with a conundrum. Given...
Read article
December 9, 2020
As a part of Cytel’s Advanced Design Framework, a new Framework for the statistical design of clinical trials, Cytel...
Read article
December 3, 2020
Increasing Clinical Development Productivity Using Statistics and Cloud-Computing The need for Re-imagining Clinical...
Read article
November 18, 2020
The current state of the clinical trials industry faces a challenge that was only hypothetical three or four years ago....
Read article
November 11, 2020
The widespread use of cloud-computing has altered the clinical trial design process. Whereas three or four years ago,...
Read article
November 4, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article
October 29, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought leaders that draws on...
Read article
October 21, 2020
Cytel has recently revealed its Advanced Design Framework, a method developed by Cytel’s thought-leaders after a decade...
Read article
October 15, 2020
For over a decade, advanced trial design techniques have promised efficient trials with accelerated timelines,...
Read article
August 18, 2020
Mrudula Joshi joined Cytel in July 2005 as a young SAS programmer. Last month, she celebrated her 15th year work...
Read article
July 11, 2020
Last week we challenged you to take a COVID-19 Clinical Development Quiz. Many of you used our Trial Tracker to find...
Read article
April 7, 2020
Cytel has industry-leading experts in Statistical Programming with years of SAS® Programming expertise and in-depth...
Read article
March 5, 2020
Generating high-quality clinical data is a vital but challenging task in modern drug development. Unfortunately, in the...
Read article
January 30, 2020
The Cytel Trial Design Innovations (CTDI) Webinar Series recently hosted a webinar on designing event-based studies....
Read article
January 22, 2020
In the quest for clinical success, we all strive for evidence packages of the highest quality. If the clinical data is...
Read article
January 16, 2020
January’s Cytel Trial Design Innovations (CTDI) Webinar Series will feature Biostatistician and pioneering Bayesian...
Read article
January 8, 2020
In clinical development, data is the vital ‘foundation’ that supports your programs. To successfully bring a promising...
Read article
December 10, 2019
In association with Statisticians in the Pharmaceutical Industry (PSI) , UCB and Cytel hosted a symposium on September...
Read article
December 5, 2019
Author: Michael S. Paas, Market Access & Commercialization Expert, Executive at AbbVie and Guest Author at Cytel In...
Read article
December 2, 2019
Author: Michael S. Paas, Market Access & Commercialization Expert, Executive at AbbVie and Guest Author at Cytel...
Read article
November 21, 2019
Author: Michael S. Paas, Market Access & Commercialization Expert, Executive at AbbVie and Guest Author at Cytel In my...
Read article
November 14, 2019
Market access strategy is an integral part of the clinical development process to ensure success in global healthcare...
Read article
April 10, 2019
In this blog, Jonathan Pritchard, Director Business Development at Cytel, draws on his experience in commercial,...
Read article
March 26, 2019
At the Partnerships in Clinical Trials Conference in Barcelona in November 2018, Strategic Consultant Ursula Garczarek...
Read article
January 10, 2019
Nand Kishore Rawat is a Director and Head, Early Phase Biostatistics based in the King of Prussia, PA Cytel office. We...
Read article
December 5, 2018
In this blog, Paul Terrill, Director of Strategic Consulting at Cytel outlines his blueprint for ensuring smooth...
Read article
April 3, 2018
By Esha Senchaudhuri In response to its R&D productivity from 2005 – 2010, AstraZeneca took the initiative in 2011 to...
Read article
March 16, 2018
At Cytel we believe that expert statistical input has the power to shape the future of clinical development: de-risking...
Read article
October 31, 2017
As part of Cytel's new Trial Innovations Webinar Series, Pat Mitchell, Statistical Science Director at AstraZeneca...
Read article
February 27, 2017
It’s been hard to miss the prevalence of estimand-related discussions in the last year. This is a topic which is very...
Read article
October 25, 2016
Use of R is a hot topic among statisticians and programmers in the pharmaceutical industry. At the recent PhUSE...
Read article
October 13, 2016
Statistical programmers play a key role in turning the data from clinical trials into knowledge and supporting the...
Read article
September 20, 2016
Drug development is an expensive and risky business. To maximize a compound’s ultimate chances of commercial as well as...
Read article
June 16, 2016
Predicting the course of a clinical trial is something which people will always want to do-whether for statistical...
Read article
June 7, 2016
At the recent CMO Summit East James ( Jim) Bolognese, Cytel’s Senior Director of Strategic Consulting, and Lou...
Read article
May 10, 2016
We were fortunate to welcome Björn Bornkamp of Novartis to the EUGM 2016 presenting work he has developed jointly with...
Read article
April 5, 2016
Cost of pharmaceutical development and R&D productivity is an ongoing industry concern, consistently discussed in the...
Read article
